Skip to main content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

Tazemetostat Hydrobromide

Placeholder slot
 (TA-zeh-MEH-toh-stat HY-droh-BROH-mide)

This page contains brief information about tazemetostat hydrobromide and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
Tazverik
FDA Approved
Yes

FDA label information for this drug is available at DailyMed.

Use in Cancer

Tazemetostat hydrobromide is approved to treat:

This use is approved under FDA’s Accelerated Approval Program. As a condition of approval, confirmatory trial(s) must show that tazemetostat hydrobromide provides a clinical benefit in these patients.

Tazemetostat hydrobromide is also being studied in the treatment of other types of cancer.

More About Tazemetostat Hydrobromide

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Research Results and Related Resources

Targeted Cancer Therapies

Clinical Trials Accepting Patients

Find Clinical Trials for Tazemetostat Hydrobromide - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted:
  • Updated: